Ponatinib Safety Profile: An Analysis of 10 Years of Real-World Experience.

Saved in:
Bibliographic Details
Title: Ponatinib Safety Profile: An Analysis of 10 Years of Real-World Experience.
Authors: Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. ejabbour@mdanderson.org., Castagnetti F; Institute of Hematology 'Seràgnoli', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Bardey-Kanaan M; Incyte Biosciences International Sàrl, Morges, Switzerland., Soichez R; Incyte Biosciences International Sàrl, Morges, Switzerland., Nguyen NT; Incyte Biosciences International Sàrl, Morges, Switzerland., Kelly D; Incyte Corporation, Wilmington, DE, USA., Rizzo F; Incyte Biosciences International Sàrl, Morges, Switzerland., Patos P; Incyte Biosciences International Sàrl, Morges, Switzerland., García-Gutiérrez V; Departamento de Hematología y Hemoterapia, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.; Universidad de Alcalá, Madrid, Spain.
Source: Drug safety [Drug Saf] 2026 Jul 18. Date of Electronic Publication: 2026 Jul 18.
Publication Type: Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42471499
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ponatinib Safety Profile: An Analysis of 10 Years of Real-World Experience.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jabbour+E%22">Jabbour E</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. ejabbour@mdanderson.org.<br /><searchLink fieldCode="AU" term="%22Castagnetti+F%22">Castagnetti F</searchLink>; Institute of Hematology 'Seràgnoli', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Bardey-Kanaan+M%22">Bardey-Kanaan M</searchLink>; Incyte Biosciences International Sàrl, Morges, Switzerland.<br /><searchLink fieldCode="AU" term="%22Soichez+R%22">Soichez R</searchLink>; Incyte Biosciences International Sàrl, Morges, Switzerland.<br /><searchLink fieldCode="AU" term="%22Nguyen+NT%22">Nguyen NT</searchLink>; Incyte Biosciences International Sàrl, Morges, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kelly+D%22">Kelly D</searchLink>; Incyte Corporation, Wilmington, DE, USA.<br /><searchLink fieldCode="AU" term="%22Rizzo+F%22">Rizzo F</searchLink>; Incyte Biosciences International Sàrl, Morges, Switzerland.<br /><searchLink fieldCode="AU" term="%22Patos+P%22">Patos P</searchLink>; Incyte Biosciences International Sàrl, Morges, Switzerland.<br /><searchLink fieldCode="AU" term="%22García-Gutiérrez+V%22">García-Gutiérrez V</searchLink>; Departamento de Hematología y Hemoterapia, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.; Universidad de Alcalá, Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229002928%22">Drug safety</searchLink> [Drug Saf] 2026 Jul 18. <i>Date of Electronic Publication: </i>2026 Jul 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9002928 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1942 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201145916%22">01145916 </searchLink><i>NLM ISO Abbreviation: </i>Drug Saf <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42471499
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40264-026-01695-1
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Ponatinib Safety Profile: An Analysis of 10 Years of Real-World Experience.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jabbour E
      – PersonEntity:
          Name:
            NameFull: Castagnetti F
      – PersonEntity:
          Name:
            NameFull: Bardey-Kanaan M
      – PersonEntity:
          Name:
            NameFull: Soichez R
      – PersonEntity:
          Name:
            NameFull: Nguyen NT
      – PersonEntity:
          Name:
            NameFull: Kelly D
      – PersonEntity:
          Name:
            NameFull: Rizzo F
      – PersonEntity:
          Name:
            NameFull: Patos P
      – PersonEntity:
          Name:
            NameFull: García-Gutiérrez V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 07
              Text: 2026 Jul 18
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1942
          Titles:
            – TitleFull: Drug safety
              Type: main
ResultId 1